- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01444053
Retrospective Study of the Health Benefits of Ultra-Violet Filtering Contact Lenses
June 16, 2017 updated by: Johnson & Johnson Vision Care, Inc.
The purpose of this study is to examine the long term effect of ultra-violet filtering contact lenses on macular pigment density (MPOD) and accommodative function.
Study Overview
Study Type
Observational
Enrollment (Actual)
41
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Birmingham, United Kingdom
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 43 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Subject selection is based on a history of wearing one of two types of contact lenses for at least five years.
Age-matching subjects into 4 age-brackets will be attempted with a target of five subjects in each age bracket among the two types of lenses.
Description
Inclusion Criteria:
- The subject is an adapted soft contact lens wearer of at least 5 years duration of either an UV filtering contact lens or a non-UV filtering contact lens
- The subject must report wearing their contact lenses, on average, for a minimum of 5 days each week.
- The subject must have best corrected visual acuity of 6/7.5 or better in each eye.
- The subject must appear able and willing to adhere to the instructions set forth in this clinical protocol.
- The subject must read and sign the statement of informed consent
- The subject must be between 18 and 43 years of age
Exclusion Criteria:
- On medication known to affect accommodation
- Active ocular surface pathology
- Had eye surgery
- Significant ocular tissue anomaly
- Any medical condition that may be prejudicial to the study
- Diabetes
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Wearers of contact lenses without UV Protection
Subjects who have worn a soft contact lens without UV protection for the past five years or more.
|
No Intervention
|
|
Wearers of contact lenses with UV Protection
Subjects who have worn a soft contact lens with UV protection for the last 5 years or more.
|
No Intervention
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Macular Pigment Optical Density (MPOD) after 5 years of contact lens wear
Time Frame: Approximately 40 minutes
|
The MPOD will be assessed at a single visit will be compared between wearers of contact lenses with UV protection and those wearers of lenses without UV protection, based on their 5 year wear history.
|
Approximately 40 minutes
|
|
Amplitude of Accommodation after 5 years of contact lens wear
Time Frame: Approximately 40 minutes
|
Measured with autorefractor at a single visit and will be compared between wearers of contact lenses with UV protection and those wearers of lenses without UV protection, based on their 5 year wear history.
|
Approximately 40 minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 2011
Primary Completion (Actual)
December 1, 2011
Study Completion (Actual)
December 1, 2011
Study Registration Dates
First Submitted
August 30, 2011
First Submitted That Met QC Criteria
September 28, 2011
First Posted (Estimate)
September 30, 2011
Study Record Updates
Last Update Posted (Actual)
June 20, 2017
Last Update Submitted That Met QC Criteria
June 16, 2017
Last Verified
June 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CR-201010
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.